Immune manifestations with checkpoint inhibitors in a single Brazilian center: experience and literature review.
Rafael A SchmerlingAntonio C BuzaidCarolina K HaddadFabio Ab SchutzFabio R KaterJuliana PimentaFernando MalufWilliam N WilliamCamila LopesDafne R BrombergAna C OliveiraRicardo GolmiaMorton Aaron ScheinbergPublished in: Future science OA (2020)
Autoimmune diseases appear in patients receiving ICIs in this real world experience. Our results differ from other series on the frequency of autoimmunity. Complete discontinuation of ICIs due to autoimmunity was rare.